chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: Patient had several mini-strokes, 10 days after vaccine, and was admitted to hospital.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Ventricular extrasystoles
Clinical narrative: Lethargic lasted 3 days. Fatigue lasted 3 days. I was diagnosed with premature ventral contractions.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: Heavy menstrual cycle following a month after vaccination and month of vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nasopharyngitis, Pyrexia
Clinical narrative: Flu like symptom's, cold and had a fever, but the next day participant stated she fine. Did not see a doctor, not that serious.
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Headache, Nausea, Palpitations
Clinical narrative: Patient developed headache, nausea and palpitations 02/12/22. Palpitations continue intermittently lasting 5-10 min.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given refrigerated Moderna that was expired beyond it's 'Beyond Use Label' date of 01/27/2022.  Vial was placed into fridge on 12/28/2021.  Vial was not removed from fridge in time for 'Beyond Use' expiry date and inadvertently administered.  Manufacturer's expiry date is March 25, 2022.  Provider informed.  Moderna informed and stated that 'the vaccine administered on January 28 to February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (covid 19) virus at time of administration'.  Patient called to inform of adverse event x 2, but unable to reach patient.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Blood gases, Blood glucose normal, Blood magnesium, Blood phosphorus
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dyspnoea, Fibrin D dimer normal, Full blood count, Inappropriate schedule of product administration
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza virus test, Metabolic function test, Oxygen saturation decreased, Platelet count decreased, Procalcitonin normal
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal impairment, Respiratory syncytial virus test, SARS-CoV-2 test positive, Tachypnoea, Troponin
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 8/13/2021 and 9/19/2021. Presented to ED 1/24/22 for increasing SOB x/10 days 2/2 COVID-19 PNA c/b acute on chronic CHF with worsening renal function. On arrival to the ED pt was tachypneic then pt desaturated to 85% on RA. ED lab work up including CBC, CMP, COVID, influenza, RSV, BNP, troponin, Mg, phos, VBG, PCT, and D-dimer notable for + COVID PCR, WBC 13.2, platelet count 81K, glucose 171, Cr 2.12 (baseline 1.8), BNP > 5000 (up from 1800), troponin 0.10, unremarkable PCT and D-dimer WNL for age. Treated w/decadron and ceftriaxone. Transitioned to comfort care, expired 1/31/22.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Atrioventricular block second degree, COVID-19, COVID-19 pneumonia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 02/03/2021 and 02/24/2021. Covid-19 + 1/10/22. Presented to ED on 1/24/22 for hypoxia after recent discharge for COVID PNA and PPM placement for finding of Mobitz type 2. Placed on BiPAP and required HFNC. Aggressively diuresed for volume overload with no respiratory improvement (13L removed). On 2/4 noted to have AKI with hyperkalemia. On 2/5 noted to be less responsive to BiPAP. Labs showed acute hypoxic and hypercarbic respiratory failure and required intubation. Transitioned to DNAR. Treated with Levaquin, Cresemba, methylprednisolone. Expired 02/05/22.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac pacemaker insertion, Death, Endotracheal intubation, Hypercapnia, Hyperkalaemia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 02/03/2021 and 02/24/2021. Covid-19 + 1/10/22. Presented to ED on 1/24/22 for hypoxia after recent discharge for COVID PNA and PPM placement for finding of Mobitz type 2. Placed on BiPAP and required HFNC. Aggressively diuresed for volume overload with no respiratory improvement (13L removed). On 2/4 noted to have AKI with hyperkalemia. On 2/5 noted to be less responsive to BiPAP. Labs showed acute hypoxic and hypercarbic respiratory failure and required intubation. Transitioned to DNAR. Treated with Levaquin, Cresemba, methylprednisolone. Expired 02/05/22.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hypervolaemia, Hypoxia, Polyuria, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 02/03/2021 and 02/24/2021. Covid-19 + 1/10/22. Presented to ED on 1/24/22 for hypoxia after recent discharge for COVID PNA and PPM placement for finding of Mobitz type 2. Placed on BiPAP and required HFNC. Aggressively diuresed for volume overload with no respiratory improvement (13L removed). On 2/4 noted to have AKI with hyperkalemia. On 2/5 noted to be less responsive to BiPAP. Labs showed acute hypoxic and hypercarbic respiratory failure and required intubation. Transitioned to DNAR. Treated with Levaquin, Cresemba, methylprednisolone. Expired 02/05/22.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Bacteraemia, COVID-19, COVID-19 pneumonia
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 01/25/2021 and 02/25/2021. Covid + 1/15/22. Recently admitted for COVID19 PNA w/symptoms starting on 12/30/21, dx on 1/1/22. Tx'd w/Actemra, remdesivir, and steroids. Discharged with dexamethasone w/4L O2.  Presented to ED 1/15/22 w/SOB. Admitted for acute hypoxemic resp failure 2/2 Covid19.  CT scan showed bilateral persistent interstitial lung disease. Chest tube placed 2/2 R pneumothorax. Intubated 1/28, course c/b MRSA pneumonia, bacteremia and septic shock. A-fib tx'd w/amiodarone.  Tx'd w/vanc, zosyn, gent, doxycycline, rocephin, ganciclovir, micafungin, dexamethasone, solumedrol. Resp status cont. to decline, transitioned to DNAR. Expired 02/11/22.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest tube insertion, Computerised tomogram thorax abnormal, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 01/25/2021 and 02/25/2021. Covid + 1/15/22. Recently admitted for COVID19 PNA w/symptoms starting on 12/30/21, dx on 1/1/22. Tx'd w/Actemra, remdesivir, and steroids. Discharged with dexamethasone w/4L O2.  Presented to ED 1/15/22 w/SOB. Admitted for acute hypoxemic resp failure 2/2 Covid19.  CT scan showed bilateral persistent interstitial lung disease. Chest tube placed 2/2 R pneumothorax. Intubated 1/28, course c/b MRSA pneumonia, bacteremia and septic shock. A-fib tx'd w/amiodarone.  Tx'd w/vanc, zosyn, gent, doxycycline, rocephin, ganciclovir, micafungin, dexamethasone, solumedrol. Resp status cont. to decline, transitioned to DNAR. Expired 02/11/22.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Interstitial lung disease, Pneumonia staphylococcal, Pneumothorax, Respiratory disorder
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 01/25/2021 and 02/25/2021. Covid + 1/15/22. Recently admitted for COVID19 PNA w/symptoms starting on 12/30/21, dx on 1/1/22. Tx'd w/Actemra, remdesivir, and steroids. Discharged with dexamethasone w/4L O2.  Presented to ED 1/15/22 w/SOB. Admitted for acute hypoxemic resp failure 2/2 Covid19.  CT scan showed bilateral persistent interstitial lung disease. Chest tube placed 2/2 R pneumothorax. Intubated 1/28, course c/b MRSA pneumonia, bacteremia and septic shock. A-fib tx'd w/amiodarone.  Tx'd w/vanc, zosyn, gent, doxycycline, rocephin, ganciclovir, micafungin, dexamethasone, solumedrol. Resp status cont. to decline, transitioned to DNAR. Expired 02/11/22.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 01/25/2021 and 02/25/2021. Covid + 1/15/22. Recently admitted for COVID19 PNA w/symptoms starting on 12/30/21, dx on 1/1/22. Tx'd w/Actemra, remdesivir, and steroids. Discharged with dexamethasone w/4L O2.  Presented to ED 1/15/22 w/SOB. Admitted for acute hypoxemic resp failure 2/2 Covid19.  CT scan showed bilateral persistent interstitial lung disease. Chest tube placed 2/2 R pneumothorax. Intubated 1/28, course c/b MRSA pneumonia, bacteremia and septic shock. A-fib tx'd w/amiodarone.  Tx'd w/vanc, zosyn, gent, doxycycline, rocephin, ganciclovir, micafungin, dexamethasone, solumedrol. Resp status cont. to decline, transitioned to DNAR. Expired 02/11/22.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Atelectasis, Atypical pneumonia, Blood lactic acid decreased, COVID-19
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 04/07/2021 and 05/05/2021. Presented to ED 1/18/22 c/o SOB, generalized weakness w/cough x4days. CT chest w/multifocal alveolar ground glass attenuation suggesting inflammation 2/2 to atypical PNA w/chronic left pleural effusion, pleural thickening, atelectasis, and scarring. Lactate of 2.7. Initial Covid test neg on 1/18, Covid test + on 1/24, steroids increased. Intubated 2/9/22, 2/2 worsening metabolic acidosis and resp distress. Developed sudden worsening of hypotension w/PEA arrest. Tx'd w/micafungin, solumedrol, remdesivir, baricitinib, vanc & zosyn. Transitioned to DNAR, expired 2/9/22.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 04/07/2021 and 05/05/2021. Presented to ED 1/18/22 c/o SOB, generalized weakness w/cough x4days. CT chest w/multifocal alveolar ground glass attenuation suggesting inflammation 2/2 to atypical PNA w/chronic left pleural effusion, pleural thickening, atelectasis, and scarring. Lactate of 2.7. Initial Covid test neg on 1/18, Covid test + on 1/24, steroids increased. Intubated 2/9/22, 2/2 worsening metabolic acidosis and resp distress. Developed sudden worsening of hypotension w/PEA arrest. Tx'd w/micafungin, solumedrol, remdesivir, baricitinib, vanc & zosyn. Transitioned to DNAR, expired 2/9/22.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Inappropriate schedule of product administration, Inflammation, Lung opacity, Metabolic acidosis
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 04/07/2021 and 05/05/2021. Presented to ED 1/18/22 c/o SOB, generalized weakness w/cough x4days. CT chest w/multifocal alveolar ground glass attenuation suggesting inflammation 2/2 to atypical PNA w/chronic left pleural effusion, pleural thickening, atelectasis, and scarring. Lactate of 2.7. Initial Covid test neg on 1/18, Covid test + on 1/24, steroids increased. Intubated 2/9/22, 2/2 worsening metabolic acidosis and resp distress. Developed sudden worsening of hypotension w/PEA arrest. Tx'd w/micafungin, solumedrol, remdesivir, baricitinib, vanc & zosyn. Transitioned to DNAR, expired 2/9/22.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pleural effusion, Pleural thickening, Pulseless electrical activity, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 04/07/2021 and 05/05/2021. Presented to ED 1/18/22 c/o SOB, generalized weakness w/cough x4days. CT chest w/multifocal alveolar ground glass attenuation suggesting inflammation 2/2 to atypical PNA w/chronic left pleural effusion, pleural thickening, atelectasis, and scarring. Lactate of 2.7. Initial Covid test neg on 1/18, Covid test + on 1/24, steroids increased. Intubated 2/9/22, 2/2 worsening metabolic acidosis and resp distress. Developed sudden worsening of hypotension w/PEA arrest. Tx'd w/micafungin, solumedrol, remdesivir, baricitinib, vanc & zosyn. Transitioned to DNAR, expired 2/9/22.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scar
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccine on 04/07/2021 and 05/05/2021. Presented to ED 1/18/22 c/o SOB, generalized weakness w/cough x4days. CT chest w/multifocal alveolar ground glass attenuation suggesting inflammation 2/2 to atypical PNA w/chronic left pleural effusion, pleural thickening, atelectasis, and scarring. Lactate of 2.7. Initial Covid test neg on 1/18, Covid test + on 1/24, steroids increased. Intubated 2/9/22, 2/2 worsening metabolic acidosis and resp distress. Developed sudden worsening of hypotension w/PEA arrest. Tx'd w/micafungin, solumedrol, remdesivir, baricitinib, vanc & zosyn. Transitioned to DNAR, expired 2/9/22.
Age: 4.0
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt received 1st dose of Havrix on 1/14/22 Lot 2JD3Y
Age: 3.0
Sex: F
Vaccine: DTAPIPV, PNC13
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse effect and will monitor.  The patient is 3 years old and 7 months. She was given Quadracel 5 month earlier.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria, Pruritus, Urticaria
Clinical narrative: Generalized itch all over body starting 14 days after Moderna booster. Hives appeared when skin was scratched. Symptoms have persisted for over 6 weeks. Diagnosed with Dermatographia on 2/16.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: symptom onset 2/4/22
Age: 17.0
Sex: M
Vaccine: FLU4, MENB, MNQ
Symptoms: Asthenia, Eye movement disorder, Hyperhidrosis, Loss of consciousness, Pallor
Clinical narrative: Pt was here for his 17yr physical exam today at 8:30am. When exam was completed, I administered the ordered vaccines:  Administered Influenza and Menactra in Left deltoid, then administered Trumenba in Right deltoid. Immediately after giving the Trumenba, pt leaned back against the wall and was grabbing his right arm. I asked if he felt ok, he said yes. I asked if he has eaten anything yet this morning and he replied no, so I gave him a juicebox. I advised pt and his mother the concern for possible passing out due to receiving vaccines early in the morning on an empty stomach. Mom assured me he was ok and I left the room.     Around 9:15am, I was alerted to patients status and went into the exam room. At that time, pt was sitting in a chair and was extremely pale. Immediately alerted provider and she came into the exam room. His eyes rolled back and seemed to have passed out, was unresponsive for about 5-10 seconds. Pt then opened his eyes and was responsive and vomited small amount onto the floor. He was weak and sweating.  Applied icepack to back of his neck, then was  given water and some pretzels. Continued to have pt sit and was monitored by RN, for about 10 more minutes. At that time, pt reprted he was feeling normal. Pt and mother felt they were comfortable to leave, they left the office around 9:31am. Advised mom to please notify office asap of any changes or symptoms today, also notify us if pt develops fever or chills tonight.
Age: 17.0
Sex: M
Vaccine: FLU4, MENB, MNQ
Symptoms: Unresponsive to stimuli, Vomiting
Clinical narrative: Pt was here for his 17yr physical exam today at 8:30am. When exam was completed, I administered the ordered vaccines:  Administered Influenza and Menactra in Left deltoid, then administered Trumenba in Right deltoid. Immediately after giving the Trumenba, pt leaned back against the wall and was grabbing his right arm. I asked if he felt ok, he said yes. I asked if he has eaten anything yet this morning and he replied no, so I gave him a juicebox. I advised pt and his mother the concern for possible passing out due to receiving vaccines early in the morning on an empty stomach. Mom assured me he was ok and I left the room.     Around 9:15am, I was alerted to patients status and went into the exam room. At that time, pt was sitting in a chair and was extremely pale. Immediately alerted provider and she came into the exam room. His eyes rolled back and seemed to have passed out, was unresponsive for about 5-10 seconds. Pt then opened his eyes and was responsive and vomited small amount onto the floor. He was weak and sweating.  Applied icepack to back of his neck, then was  given water and some pretzels. Continued to have pt sit and was monitored by RN, for about 10 more minutes. At that time, pt reprted he was feeling normal. Pt and mother felt they were comfortable to leave, they left the office around 9:31am. Advised mom to please notify office asap of any changes or symptoms today, also notify us if pt develops fever or chills tonight.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Intensive care, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with Janssen, and boosted.   COVID infection breakthrough and inpatient ICU stay
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered is inappropriate based on patient age.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid -19 Case
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: symptom onset 2/13/22
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Blood follicle stimulating hormone decreased, Blood luteinising hormone decreased, Blood test, Endometrial thickening
Clinical narrative: I had my last menstrual period in December 20 20 and did not bleed again throughout the year 2021 during which I had all of these vaccines. In January 2022, I experienced extreme debilitating abdominal cramping and Menorrhagia, which repeated in  February. I wanted to report it because I can?t find any other logical reason why my menopause reversed itself except for all the vaccines.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Heavy menstrual bleeding, Hysteroscopy abnormal, Postmenopausal haemorrhage, Ultrasound scan normal
Clinical narrative: I had my last menstrual period in December 20 20 and did not bleed again throughout the year 2021 during which I had all of these vaccines. In January 2022, I experienced extreme debilitating abdominal cramping and Menorrhagia, which repeated in  February. I wanted to report it because I can?t find any other logical reason why my menopause reversed itself except for all the vaccines.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urine analysis, Uterine dilation and curettage
Clinical narrative: I had my last menstrual period in December 20 20 and did not bleed again throughout the year 2021 during which I had all of these vaccines. In January 2022, I experienced extreme debilitating abdominal cramping and Menorrhagia, which repeated in  February. I wanted to report it because I can?t find any other logical reason why my menopause reversed itself except for all the vaccines.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Full blood count, International normalised ratio, Prothrombin level, Prothrombin time
Clinical narrative: Epistaxis
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Electrocardiogram, Heart rate increased, Palpitations, X-ray
Clinical narrative: rapid heart beat, palpitations
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given refrigerated Moderna that was expired beyond it's 'Beyond Use Label' date of 01/27/2022.  Vial was placed into fridge on 12/28/2021.  Vial was not removed from fridge in time for 'Beyond Use' expiry date and inadvertently administered.  Manufacturer's expiry date is March 25, 2022.  Provider informed.  Moderna informed and stated that 'the vaccine administered on January 28 to February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (covid 19) virus at time of administration'.   Patient phoned and informed and stated no adverse effects.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Artificial rupture of membranes, COVID-19, Complication of pregnancy, Delivery, Drug abuse
Clinical narrative: Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC)  Fibroid uterus  Blood type, Rh positive  Tetrahydrocannabinol (THC) use disorder, mild, abuse  Rubella immune  SVD (spontaneous vaginal delivery)  High risk HPV infection  Obesity affecting pregnancy in second trimester   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Epidural     OB Complications:  Pre-eclampsia    Cervical Ripening Type: Misoprostol  Cervical Ripening Comment:      Induction: AROM;Cervical Ripening   Induction Indications: Chronic Hypertension    Augmentation: Oxytocin    Delivery Date: 1/17/2022  Delivery Time: 7:53 AM  Gestational Age(weeks days/7): 39 2/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.098 kg (6 lb 13.3 oz)   Sex: male   Apgar Score (1 min): 9   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Patient with uncomplicated post-partum recovery.  On the day of discharge pain was well controlled with oral pain meds, she was ambulating and voiding without difficulty, and was tolerating diet without nausea/vomiting.  Patient was requesting discharge home.  Following complete examination and review of recovery course, patient was deemed stable for discharge. Patient will need a blood pressure check in 3 days.     Procedures performed: SVD with repair of second degree and right periurethral    Discharge       All Hospital Problems (Other diagnoses): Active Hospital Problems   Diagnosis ? Principal Problem: SVD (spontaneous vaginal delivery) [O80] ? Chronic hypertension with superimposed pre-eclampsia [O11.9] ? Rubella immune [Z78.9] ? Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC) [E66.01, Z68.42] ? Blood type, Rh positive [Z67.90] ? Fibroid uterus [D25.9]   Resolved Hospital Problems No resolved problems to display.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Hypertension, Induction of cervix ripening, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC)  Fibroid uterus  Blood type, Rh positive  Tetrahydrocannabinol (THC) use disorder, mild, abuse  Rubella immune  SVD (spontaneous vaginal delivery)  High risk HPV infection  Obesity affecting pregnancy in second trimester   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Epidural     OB Complications:  Pre-eclampsia    Cervical Ripening Type: Misoprostol  Cervical Ripening Comment:      Induction: AROM;Cervical Ripening   Induction Indications: Chronic Hypertension    Augmentation: Oxytocin    Delivery Date: 1/17/2022  Delivery Time: 7:53 AM  Gestational Age(weeks days/7): 39 2/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.098 kg (6 lb 13.3 oz)   Sex: male   Apgar Score (1 min): 9   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Patient with uncomplicated post-partum recovery.  On the day of discharge pain was well controlled with oral pain meds, she was ambulating and voiding without difficulty, and was tolerating diet without nausea/vomiting.  Patient was requesting discharge home.  Following complete examination and review of recovery course, patient was deemed stable for discharge. Patient will need a blood pressure check in 3 days.     Procedures performed: SVD with repair of second degree and right periurethral    Discharge       All Hospital Problems (Other diagnoses): Active Hospital Problems   Diagnosis ? Principal Problem: SVD (spontaneous vaginal delivery) [O80] ? Chronic hypertension with superimposed pre-eclampsia [O11.9] ? Rubella immune [Z78.9] ? Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC) [E66.01, Z68.42] ? Blood type, Rh positive [Z67.90] ? Fibroid uterus [D25.9]   Resolved Hospital Problems No resolved problems to display.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Labour augmentation, Obesity, Pain, Papilloma viral infection, Perineal injury
Clinical narrative: Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC)  Fibroid uterus  Blood type, Rh positive  Tetrahydrocannabinol (THC) use disorder, mild, abuse  Rubella immune  SVD (spontaneous vaginal delivery)  High risk HPV infection  Obesity affecting pregnancy in second trimester   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Epidural     OB Complications:  Pre-eclampsia    Cervical Ripening Type: Misoprostol  Cervical Ripening Comment:      Induction: AROM;Cervical Ripening   Induction Indications: Chronic Hypertension    Augmentation: Oxytocin    Delivery Date: 1/17/2022  Delivery Time: 7:53 AM  Gestational Age(weeks days/7): 39 2/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.098 kg (6 lb 13.3 oz)   Sex: male   Apgar Score (1 min): 9   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Patient with uncomplicated post-partum recovery.  On the day of discharge pain was well controlled with oral pain meds, she was ambulating and voiding without difficulty, and was tolerating diet without nausea/vomiting.  Patient was requesting discharge home.  Following complete examination and review of recovery course, patient was deemed stable for discharge. Patient will need a blood pressure check in 3 days.     Procedures performed: SVD with repair of second degree and right periurethral    Discharge       All Hospital Problems (Other diagnoses): Active Hospital Problems   Diagnosis ? Principal Problem: SVD (spontaneous vaginal delivery) [O80] ? Chronic hypertension with superimposed pre-eclampsia [O11.9] ? Rubella immune [Z78.9] ? Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC) [E66.01, Z68.42] ? Blood type, Rh positive [Z67.90] ? Fibroid uterus [D25.9]   Resolved Hospital Problems No resolved problems to display.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory syncytial virus test negative, Rhesus antigen positive, Rubella immunity confirmed, SARS-CoV-2 test positive, Superimposed pre-eclampsia
Clinical narrative: Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC)  Fibroid uterus  Blood type, Rh positive  Tetrahydrocannabinol (THC) use disorder, mild, abuse  Rubella immune  SVD (spontaneous vaginal delivery)  High risk HPV infection  Obesity affecting pregnancy in second trimester   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Epidural     OB Complications:  Pre-eclampsia    Cervical Ripening Type: Misoprostol  Cervical Ripening Comment:      Induction: AROM;Cervical Ripening   Induction Indications: Chronic Hypertension    Augmentation: Oxytocin    Delivery Date: 1/17/2022  Delivery Time: 7:53 AM  Gestational Age(weeks days/7): 39 2/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.098 kg (6 lb 13.3 oz)   Sex: male   Apgar Score (1 min): 9   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Patient with uncomplicated post-partum recovery.  On the day of discharge pain was well controlled with oral pain meds, she was ambulating and voiding without difficulty, and was tolerating diet without nausea/vomiting.  Patient was requesting discharge home.  Following complete examination and review of recovery course, patient was deemed stable for discharge. Patient will need a blood pressure check in 3 days.     Procedures performed: SVD with repair of second degree and right periurethral    Discharge       All Hospital Problems (Other diagnoses): Active Hospital Problems   Diagnosis ? Principal Problem: SVD (spontaneous vaginal delivery) [O80] ? Chronic hypertension with superimposed pre-eclampsia [O11.9] ? Rubella immune [Z78.9] ? Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC) [E66.01, Z68.42] ? Blood type, Rh positive [Z67.90] ? Fibroid uterus [D25.9]   Resolved Hospital Problems No resolved problems to display.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Urethral injury, Uterine leiomyoma, Wound closure
Clinical narrative: Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC)  Fibroid uterus  Blood type, Rh positive  Tetrahydrocannabinol (THC) use disorder, mild, abuse  Rubella immune  SVD (spontaneous vaginal delivery)  High risk HPV infection  Obesity affecting pregnancy in second trimester   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Epidural     OB Complications:  Pre-eclampsia    Cervical Ripening Type: Misoprostol  Cervical Ripening Comment:      Induction: AROM;Cervical Ripening   Induction Indications: Chronic Hypertension    Augmentation: Oxytocin    Delivery Date: 1/17/2022  Delivery Time: 7:53 AM  Gestational Age(weeks days/7): 39 2/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.098 kg (6 lb 13.3 oz)   Sex: male   Apgar Score (1 min): 9   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Patient with uncomplicated post-partum recovery.  On the day of discharge pain was well controlled with oral pain meds, she was ambulating and voiding without difficulty, and was tolerating diet without nausea/vomiting.  Patient was requesting discharge home.  Following complete examination and review of recovery course, patient was deemed stable for discharge. Patient will need a blood pressure check in 3 days.     Procedures performed: SVD with repair of second degree and right periurethral    Discharge       All Hospital Problems (Other diagnoses): Active Hospital Problems   Diagnosis ? Principal Problem: SVD (spontaneous vaginal delivery) [O80] ? Chronic hypertension with superimposed pre-eclampsia [O11.9] ? Rubella immune [Z78.9] ? Class 3 severe obesity with body mass index (BMI) of 45.0 to 49.9 in adult (CMS/HCC) [E66.01, Z68.42] ? Blood type, Rh positive [Z67.90] ? Fibroid uterus [D25.9]   Resolved Hospital Problems No resolved problems to display.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Lichen planus
Clinical narrative: Patient developed Lichen Planus.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests normal, Dizziness, Gait disturbance, Impaired driving ability, Impaired work ability
Clinical narrative: After I received the booster shot I was okay for the first ten days , after those ten days I woke up on the 30th and I felt like I was spinning so I laid back down as I was unable to get up until about two that afternoon, I was unable to drive . I took off from work for the day and for about two weeks after I was feeling dizzy randomly to the point where walking was a little harder. After the two weeks I was able to drive again . At the begging of January i had an MRI done and a hearing test done. both came back clear get up but i still feel dizzy at times when i get up to fast. If I move my neck to fast I feel dizzy.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Mobility decreased, Vertigo
Clinical narrative: After I received the booster shot I was okay for the first ten days , after those ten days I woke up on the 30th and I felt like I was spinning so I laid back down as I was unable to get up until about two that afternoon, I was unable to drive . I took off from work for the day and for about two weeks after I was feeling dizzy randomly to the point where walking was a little harder. After the two weeks I was able to drive again . At the begging of January i had an MRI done and a hearing test done. both came back clear get up but i still feel dizzy at times when i get up to fast. If I move my neck to fast I feel dizzy.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, Binge drinking, Blood creatinine increased, Blood lactic acid
Clinical narrative: Chief Complaint:  resp distress, lethargy   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 35y.o. male    per ems " pt called us for DIB, when we arrived pt was unresponsive , narcan was given, pt lost pulses for a few minutes CPR was started pt regained consciousness. bloody vomited was found in toilet. Patient at that time regained consciousness with hematemesis. Mentation improved after bag valve masking the patient. Narcan was also given for possible overdose, but patient did not seem to have any improvement after.   At time of exam patient is still sleepy although more arousable than previously.  He is in the ICU.  Remains on an insulin drip.  No specific complaint identified although remains sleepy He was started on empiric antibiotic therapy. He required transient vasopressor support which is now been weaned.  He was also found to have acute kidney injury with creatinine 6.8.  Initial lactic acid was 21.5 troponin was elevated.   He was previously triaged in the emergency 1/15/2022, brought in by EMS with abdominal pain and shortness of breath after binge drinking for 5 days whiskey.  He left AMA. He tested positive for COVID on 1/16/2022
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Depressed level of consciousness, Dyspnoea, Haematemesis, Intensive care
Clinical narrative: Chief Complaint:  resp distress, lethargy   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 35y.o. male    per ems " pt called us for DIB, when we arrived pt was unresponsive , narcan was given, pt lost pulses for a few minutes CPR was started pt regained consciousness. bloody vomited was found in toilet. Patient at that time regained consciousness with hematemesis. Mentation improved after bag valve masking the patient. Narcan was also given for possible overdose, but patient did not seem to have any improvement after.   At time of exam patient is still sleepy although more arousable than previously.  He is in the ICU.  Remains on an insulin drip.  No specific complaint identified although remains sleepy He was started on empiric antibiotic therapy. He required transient vasopressor support which is now been weaned.  He was also found to have acute kidney injury with creatinine 6.8.  Initial lactic acid was 21.5 troponin was elevated.   He was previously triaged in the emergency 1/15/2022, brought in by EMS with abdominal pain and shortness of breath after binge drinking for 5 days whiskey.  He left AMA. He tested positive for COVID on 1/16/2022
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Loss of consciousness, Mental status changes, Pulse absent, Respiratory distress
Clinical narrative: Chief Complaint:  resp distress, lethargy   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 35y.o. male    per ems " pt called us for DIB, when we arrived pt was unresponsive , narcan was given, pt lost pulses for a few minutes CPR was started pt regained consciousness. bloody vomited was found in toilet. Patient at that time regained consciousness with hematemesis. Mentation improved after bag valve masking the patient. Narcan was also given for possible overdose, but patient did not seem to have any improvement after.   At time of exam patient is still sleepy although more arousable than previously.  He is in the ICU.  Remains on an insulin drip.  No specific complaint identified although remains sleepy He was started on empiric antibiotic therapy. He required transient vasopressor support which is now been weaned.  He was also found to have acute kidney injury with creatinine 6.8.  Initial lactic acid was 21.5 troponin was elevated.   He was previously triaged in the emergency 1/15/2022, brought in by EMS with abdominal pain and shortness of breath after binge drinking for 5 days whiskey.  He left AMA. He tested positive for COVID on 1/16/2022
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Resuscitation, SARS-CoV-2 test positive, Somnolence, Troponin increased, Unresponsive to stimuli
Clinical narrative: Chief Complaint:  resp distress, lethargy   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 35y.o. male    per ems " pt called us for DIB, when we arrived pt was unresponsive , narcan was given, pt lost pulses for a few minutes CPR was started pt regained consciousness. bloody vomited was found in toilet. Patient at that time regained consciousness with hematemesis. Mentation improved after bag valve masking the patient. Narcan was also given for possible overdose, but patient did not seem to have any improvement after.   At time of exam patient is still sleepy although more arousable than previously.  He is in the ICU.  Remains on an insulin drip.  No specific complaint identified although remains sleepy He was started on empiric antibiotic therapy. He required transient vasopressor support which is now been weaned.  He was also found to have acute kidney injury with creatinine 6.8.  Initial lactic acid was 21.5 troponin was elevated.   He was previously triaged in the emergency 1/15/2022, brought in by EMS with abdominal pain and shortness of breath after binge drinking for 5 days whiskey.  He left AMA. He tested positive for COVID on 1/16/2022
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Atrial flutter, Blood test normal, Cardiac ablation, Condition aggravated
Clinical narrative: Episodes of angioedema of tongue increased; three or four in 2020 to about 16 or 17 in 2022.  Had an episode the week before the first shot; then another a week or two after the second shot (got second shot on 2/12/21, booster on 10/08/21) and about every three weeks after that.  Previously they were much more spaced out and less regular.  Controlled with prednisone, usually (sometimes goes away on its own.)  Also developed atrial flutter in April, 2021; Hospitalized for a few days. Cardiac ablation performed in May.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal
Clinical narrative: Episodes of angioedema of tongue increased; three or four in 2020 to about 16 or 17 in 2022.  Had an episode the week before the first shot; then another a week or two after the second shot (got second shot on 2/12/21, booster on 10/08/21) and about every three weeks after that.  Previously they were much more spaced out and less regular.  Controlled with prednisone, usually (sometimes goes away on its own.)  Also developed atrial flutter in April, 2021; Hospitalized for a few days. Cardiac ablation performed in May.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Manufacturer inappropriate based on patient age.
Age: 1.67
Sex: F
Vaccine: DTAP, HEPA
Symptoms: Peripheral swelling, Urticaria
Clinical narrative: swelling to both hands, swelling to both feet,  hives on extremities and face
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Injection site swelling, Pain, Urticaria
Clinical narrative: Chills, teeth chattering, body aches, and swelling/redness in injection arm lasting 24 hours. Two days later hives under right arm, extending from armpit to midway down torso on right side. I was put on oral prednisone and Benadryl.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given refrigerated Moderna that was expired beyond it's 'Beyond Use Label' date of 01/27/2022.  Vial was placed into fridge on 12/28/2021.  Vial was not removed from fridge in time for 'Beyond Use' expiry date and inadvertently administered.  Manufacturer's expiry date is March 25, 2022.  Provider informed.  Moderna informed and stated that 'the vaccine administered on January 28 to February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (covid 19) virus at time of administration'.   Patient called and informed of adverse event, no adverse effects noted.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, Menstruation irregular
Clinical narrative: 2 week delay in period. Longer cycles in general. Went from 30-36 day cycle to 44 and it remains irregular to date.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: THERE WERE NO ADVERSE EVENTS TO REPORT. THIS REPORT IS BEING FILED BEACUSE THE PATIENT WAS ADMINISTERED A BOOSTER DOSE FROM A VIAL OF MODERNA VACCINE THAT HAD BEEN OUT OF THE REFRIGERATOR FOR MORE THAN 12  HOURS.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: reports muscle twitches in face, arms and legs since vaccination on 2/14/22
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical urticaria
Clinical narrative: Dermatographia
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Confusional state, Dehydration, Dizziness
Clinical narrative: Pt. states that after receiving the 3rd dose of Moderna 12/23/2021, started experiencing symptoms that evening of both sides of the throat swelling (Lymphnoids), fatigued, weakness, chills, and severe headache. Severe pain (tearing sensation) in the right arm from shoulder down and around the injection site. Dry heaving, ringing in both ears, both legs from the knees down pain, dizziness, difficulty walking (contractions in the back), stiffness throughout the back area, confusion, (low-grade) fever, difficulty sleeping, numbness, tingling sensation in the lower extremities, and severe dehydration. Symptoms have subsided within  72hrs after vaccination. Primary visit 02/16/2022 with recommendations of reporting.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Headache, Hypoaesthesia, Injection site pain
Clinical narrative: Pt. states that after receiving the 3rd dose of Moderna 12/23/2021, started experiencing symptoms that evening of both sides of the throat swelling (Lymphnoids), fatigued, weakness, chills, and severe headache. Severe pain (tearing sensation) in the right arm from shoulder down and around the injection site. Dry heaving, ringing in both ears, both legs from the knees down pain, dizziness, difficulty walking (contractions in the back), stiffness throughout the back area, confusion, (low-grade) fever, difficulty sleeping, numbness, tingling sensation in the lower extremities, and severe dehydration. Symptoms have subsided within  72hrs after vaccination. Primary visit 02/16/2022 with recommendations of reporting.